Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Sales | 5,497,000 | 4,563,000 | 4,418,000 | 4,451,000 | 5,408,000 |
| Cost of Goods | 794,000 | 1,200,000 | 1,130,000 | 1,141,000 | 1,471,000 |
| Gross Profit | 2,324,000 | 3,363,000 | 3,288,000 | 3,310,000 | 3,937,000 |
| Operating Expenses | 1,042,000 | 1,836,000 | 1,927,000 | 1,780,000 | 2,396,000 |
| Operating Income | 3,661,000 | 1,527,000 | 1,361,000 | 1,530,000 | 1,541,000 |
| Other Income | -2,501,000 | -386,000 | 0 | 0 | -86,000 |
| Pre-tax Income | 1,160,000 | 1,141,000 | 1,361,000 | 1,530,000 | 1,455,000 |
| Income Tax | 269,000 | 248,000 | 356,000 | 401,000 | 403,000 |
| Net Income Continuous | 1,163,000 | 893,000 | 1,005,000 | 1,129,000 | 1,052,000 |
| Net Income Discontinuous | N/A | 343,000 | 86,000 | 92,000 | 0 |
| Net Income | $1,163,000 | $1,236,000 | $1,091,000 | $1,221,000 | $1,052,000 |
| EPS Basic Total Ops | 0.60 | 0.63 | 0.55 | 0.62 | 0.53 |
| EPS Basic Continuous Ops | 0.60 | 0.45 | 0.51 | 0.57 | 0.53 |
| EPS Basic Discontinuous Ops | 0.06 | 0.18 | 0.04 | 0.05 | N/A |
| EPS Diluted Total Ops | 0.59 | 0.62 | 0.54 | 0.61 | 0.52 |
| EPS Diluted Continuous Ops | 0.59 | 0.45 | 0.50 | 0.56 | 0.53 |
| EPS Diluted Discontinuous Ops | 0.06 | 0.17 | 0.04 | 0.05 | N/A |
| EBITDA(a) | $3,847,000 | $1,714,000 | $1,547,000 | $1,717,000 | $1,730,000 |